108 related articles for article (PubMed ID: 3178872)
41. Factors influencing peroxisome proliferation in cultured rat hepatocytes.
Mitchell AM; Bridges JW; Elcombe CR
Arch Toxicol; 1984 Oct; 55(4):239-46. PubMed ID: 6517701
[TBL] [Abstract][Full Text] [Related]
42. Hypolipidemic effect of beta, beta'-methyl-substituted hexadecanedioic acid (MEDICA 16) in normal and nephrotic rats.
Bar-Tana J; Rose-Kahn G; Frenkel B; Shafer Z; Fainaru M
J Lipid Res; 1988 Apr; 29(4):431-41. PubMed ID: 3392461
[TBL] [Abstract][Full Text] [Related]
43. Participation of peroxisomes in the metabolism of xenobiotic acyl compounds: comparison between peroxisomal and mitochondrial beta-oxidation of omega-phenyl fatty acids in rat liver.
Yamada J; Ogawa S; Horie S; Watanabe T; Suga T
Biochim Biophys Acta; 1987 Sep; 921(2):292-301. PubMed ID: 3651489
[TBL] [Abstract][Full Text] [Related]
44. Induction of peroxisomal beta-oxidation by structural analogues of dehydroepiandrosterone in cultured rat hepatocytes: structure-activity relationships.
Sakuma M; Yamada J; Suga T
Biochim Biophys Acta; 1993 Jul; 1169(1):66-72. PubMed ID: 8334152
[TBL] [Abstract][Full Text] [Related]
45. Effects of added l-carnitine, acetyl-CoA and CoA on peroxisomal beta-oxidation of [U-14C]hexadecanoate by isolated peroxisomal fractions.
Sleboda J; Pourfarzam M; Bartlett K; Osmundsen H
Biochim Biophys Acta; 1995 Oct; 1258(3):309-18. PubMed ID: 7548202
[TBL] [Abstract][Full Text] [Related]
46. Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III.
Hertz R; Bishara-Shieban J; Bar-Tana J
J Biol Chem; 1995 Jun; 270(22):13470-5. PubMed ID: 7768950
[TBL] [Abstract][Full Text] [Related]
47. The short- and long-term effects of bezafibrate in the rat.
Fahimi HD; Reinicke A; Sujatta M; Yokota S; Ozel M; Hartig F; Stegmeier K
Ann N Y Acad Sci; 1982; 386():111-35. PubMed ID: 6953842
[TBL] [Abstract][Full Text] [Related]
48. Differences in the response of Sprague-Dawley and Lewis rats to bezafibrate: the hypolipidemic effect and the induction of peroxisomal enzymes.
Pill J; Völkl A; Hartig F; Fahimi HD
Arch Toxicol; 1992; 66(5):327-33. PubMed ID: 1610295
[TBL] [Abstract][Full Text] [Related]
49. Characteristics of dehydroepiandrosterone as a peroxisome proliferator.
Yamada J; Sakuma M; Ikeda T; Fukuda K; Suga T
Biochim Biophys Acta; 1991 Apr; 1092(2):233-43. PubMed ID: 1673353
[TBL] [Abstract][Full Text] [Related]
50. Peroxisome proliferation and beta-oxidation in Fao and MH1C1 rat hepatoma cells, HepG2 human hepatoblastoma cells and cultured human hepatocytes: effect of ciprofibrate.
Duclos S; Bride J; Ramirez LC; Bournot P
Eur J Cell Biol; 1997 Apr; 72(4):314-23. PubMed ID: 9127731
[TBL] [Abstract][Full Text] [Related]
51. Characteristics of the suppressive effect of nicardipine on peroxisome induction in rat liver.
Itoga H; Tamura H; Watanabe T; Suga T
Biochim Biophys Acta; 1990 Jan; 1051(1):21-8. PubMed ID: 2297537
[TBL] [Abstract][Full Text] [Related]
52. Suppression of clofibrate-induced peroxisome proliferation in rat liver by nicardipine, a calcium antagonist.
Watanabe T; Suga T
FEBS Lett; 1988 May; 232(2):293-7. PubMed ID: 2897936
[TBL] [Abstract][Full Text] [Related]
53. Hypocholesterolaemic effect of beta beta'-methyl-substituted hexadecanedioic acid (MEDICA 16) in the male hamster.
Mayorek N; Bar-Tana J
Biochem J; 1993 Feb; 289 ( Pt 3)(Pt 3):911-7. PubMed ID: 8435085
[TBL] [Abstract][Full Text] [Related]
54. Zonal heterogeneity of peroxisomal enzymes in rat liver: differential induction by three divergent hypolipidemic drugs.
Lindauer M; Beier K; Völkl A; Fahimi HD
Hepatology; 1994 Aug; 20(2):475-86. PubMed ID: 7913908
[TBL] [Abstract][Full Text] [Related]
55. Metabolic aspects of peroxisomal beta-oxidation.
Osmundsen H; Bremer J; Pedersen JI
Biochim Biophys Acta; 1991 Sep; 1085(2):141-58. PubMed ID: 1892883
[TBL] [Abstract][Full Text] [Related]
56. Increased response to peroxisomal proliferators in starved rats.
Hertz R; Bar-Tana J
Biochim Biophys Acta; 1987 Jan; 917(1):57-61. PubMed ID: 3790611
[TBL] [Abstract][Full Text] [Related]
57. Effect of beta, beta'-tetramethyl-substituted hexadecanedioic acid (MEDICA 16) on laying hen performance and egg yolk lipid composition.
Elkin RG; Rogler JC; Lee HD; Watkins BA
Br Poult Sci; 1992 Jul; 33(3):677-81. PubMed ID: 1643530
[TBL] [Abstract][Full Text] [Related]
58. Involvement of calmodulin- and protein kinase C-related mechanism in an induction process of peroxisomal fatty acid oxidation-related enzymes by hypolipidemic peroxisome proliferators.
Watanabe T; Okawa S; Itoga H; Imanaka T; Suga T
Biochim Biophys Acta; 1992 Apr; 1135(1):84-90. PubMed ID: 1591274
[TBL] [Abstract][Full Text] [Related]
59. The effect of retinoids and clofibric acid on the peroxisomal oxidation of palmitic acid and of 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholestanoic acid in rat and rabbit hepatocytes.
Farrants AK; Nilsson A; Trøen G; Blomhoff R; Pedersen JI
Biochim Biophys Acta; 1993 May; 1168(1):100-7. PubMed ID: 8504135
[TBL] [Abstract][Full Text] [Related]
60. Purification and properties of peroxisomal carnitine palmitoyltransferase in chick embryo liver.
Ishii S; Ishii H; Watanabe T; Suga T
Biochim Biophys Acta; 1987 Jun; 924(3):530-42. PubMed ID: 3593765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
